247259-33-2

Basic information

• Product Name: 4-piperidineacetic acid, 1-(phenylmethyl)-, methyl ester
• Synonyms: 4-piperidineacetic acid, 1-(phenylmethyl)-, methyl ester;methyl (1-benzylpiperidin-4-yl)acetate;2-[1-(benzyl)-4-piperidyl]acetic acid methyl ester;2-[1-(phenylmethyl)-4-piperidinyl]acetic acid methyl ester;methyl (1-benzylpiperidin-4-yl)acetate hydrochloride;methyl 2-[1-(phenylmethyl)-4-piperidyl]acetate;methyl 2-[1-(phenylmethyl)piperidin-4-yl]acetate;methyl 2-[1-(phenylmethyl)piperidin-4-yl]ethanoate
• CAS NO: 247259-33-2
• Molecular Formula: C15H21NO2
• Molecular Weight: 247.33274
• Mol File: 247259-33-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-piperidineacetic acid, 1-(phenylmethyl)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-piperidineacetic acid, 1-(phenylmethyl)-, methyl ester(247259-33-2)
• EPA Substance Registry System: 4-piperidineacetic acid, 1-(phenylmethyl)-, methyl ester(247259-33-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 247259-33-2(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 81270-37-3 methyl piperidine-4-acetate hydrochloride 
• 3612-20-2 1-phenylmethyl-4-piperidone 
• 206558-34-1 C₁₅H₁₉NO₂ 
• 70199-68-7 methyl 4-pyridylacetate hydrochloride 
• 54401-85-3 pyridin-4-yl-acetic acid ethyl ester 

Downstream Products

• 865626-97-7 (±)-3-(1-benzylpiperidin-4-yl)-4-hydroxy-3,4-dihydroquinolin-2(1H)-one 
• 865626-98-8 3-(1-benzylpiperidin-4-yl)quinolin-2(1H)-one 
• 912463-38-8 4-nitrophenyl 4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxylate 
• 1458062-06-0 (±)-1-(7-benzyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazin-3-yl)-2-(7-methyl-2-((2-(trimethylsilyl)ethoxy)methyl)-2H-indazol-5-yl)ethyl 4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxylate 
• 1458062-08-2 (±)-1-(7-benzyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazin-3-yl)-2-(7-methyl-1H-indazol-5-yl)ethyl 4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxylate 

Relevant articles and documents

TETRAHYDROIMDIDAZOPYRAZINE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS

The disclosure generally relates to the novel compounds of formula I, including pharmaceutically acceptable salts, which are CGRP receptor antagonists. The disclosure also relates to pharmaceutical compositions and methods for using the compounds in the t

Novel therapeutic agents for the treatment of migraine

The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their u

Synthesis and Pharmacology of Site-Specific Cocaine Abuse Treatment Agents: The Role of the Phenyl Group in Highly Modified Methylphenidate analogs as Dopamine Uptake Inhibitors

A series of modified methylphenidate derivatives was synthesized and tested for inhibitory potency in [3H]WIN 35,428 binding and [3H]dopamine uptake assays using rat striatal tissue. In these compounds the role of the phenyl ring was investigated by its r